Literature DB >> 4049955

The influence of two different essential amino acid/keto analogue preparations on the clinical status of patients with chronic renal failure.

E Meisinger, M Strauch.   

Abstract

58 outpatients with a serum creatinine between 6-10 mg/dl received a low protein diet (LPD) with 30 g protein/day, supplemented with essential amino acids (EAA) or their keto analogues (KA). Group A (n = 19) was given an EAA/KA supplement according to the pattern proposed by Rose and group B (n = 39) received a preparation with an increased amount of KAs of branched chain amino acids (BCKA), as recommended by Walser. At the start of treatment with a LPD supplemented with either of the two supplements and after 6 months of treatment we assessed: plasma branched chain amino acids (BCAA), renal function, nutritional status, and bone metabolism. After six months of dietary treatment the results showed in group B in contrast to group A an improvement of nutritional status (body weight increased, urea decreased, and BCAA normalized). The same was true for bone metabolism (significantly lower phosphate levels, increased calcium values). In both groups progression of chronic renal failure slowed down, but the delay was more pronounced in group B. All results were statistically significant (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049955     DOI: 10.1007/BF02020456

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  14 in total

1.  Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial.

Authors:  G Barsotti; E Morelli; A Giannoni; A Guiducci; S Lupetti; S Giovannetti
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

2.  Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.

Authors:  G Maschio; L Oldrizzi; N Tessitore; A D'Angelo; E Valvo; A Lupo; C Loschiavo; A Fabris; L Gammaro; C Rugiu
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

3.  Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure.

Authors:  A Ando; Y Orita; K Nakata; Y Tsubakihara; Y Takamitsu; N Ueda; M Yanase; H Abe
Journal:  Nephron       Date:  1979       Impact factor: 2.847

4.  The effect of keto-analogues of essential amino acids in severe chronic uremia.

Authors:  M Walser; A W Coulter; S Dighe; F R Crantz
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

5.  Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure.

Authors:  P T Fröhling; F Kokot; R Schmicker; I Kaschube; K Lindenau; K Vetter
Journal:  Clin Nephrol       Date:  1983-10       Impact factor: 0.975

6.  Plasma and muscle free amino acids in uremia: influence of nutrition with amino acids.

Authors:  A Alvestrand; P Fürst; J Bergström
Journal:  Clin Nephrol       Date:  1982-12       Impact factor: 0.975

7.  Supplements containing amino acids and keto acids in the treatment of chronic uremia.

Authors:  M Walser; W E Mitch; E Abras
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

8.  Comparison of three low-nitrogen diets containing essential amino acids and their alpha analogues for severely uremic children.

Authors:  M Broyer; M Guillot; P Niaudet; C Kleinknecht; A M Dartois; G Jean
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

9.  Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia.

Authors:  A Alvestrand; M Ahlberg; P Fürst; J Bergström
Journal:  Clin Nephrol       Date:  1983-02       Impact factor: 0.975

10.  Decarboxylation of alpha-ketoisovaleric acid after oral administration in man.

Authors:  C M Epstein; R K Chawla; A Wadsworth; D Rudman
Journal:  Am J Clin Nutr       Date:  1980-09       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.